ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joginder Bhayana
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raab, T. A.
Right arrow Articles by Beam, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raab, T. A.
Right arrow Articles by Beam, T. R., Jr.

Ann Thorac Surg 1982;33:340-344
© 1982 The Society of Thoracic Surgeons

Articles

A Comparison of the Safety, Efficacy, and Distribution of Ceforanide and Cephalothin in Coronary Artery Bypass Graft Surgery

Thomas A. Raab, M.D., Samuel Balderman, M.D., Joginder Bhayana, M.D., Kathy Bingham, R.N., Joseph Mylotte, M.D., Thomas R. Beam, Jr., M.D.*

From the Cardiothoracic, Surgery and Infectious Diseases Services, Buffalo Veterans Administration Medical Center, and the Departments of Surgery and Medicine, State University of New York at Buffalo, Buffalo, NY.

Accepted for publication October 15, 1981.

* Address reprint requests to Dr. Beam, Chief, Infectious Diseases (111F), Buffalo VA Medical Center, 3495 Bailey Ave, Buffalo, NY 14215.

Antibiotic prophylaxis in open-heart operations is a widely accepted practice. Introduction of new antibiotics with differences in tissue distribution, spectrum of activity, and therapeutic index prompts their evaluation as possible effective prophylactic agents. We compared the distribution, clinical efficacy, and safety of ceforanide with cephalothin as a prophylactic agent in coronary artery bypass graft (CABG) procedures. The results indicated that the intravenous administration of ceforanide at the dose of 1 gm every 12 hours for 2.5 days was equivalent to cephalothin 1 gm every 6 hours for 2.5 days. Serum, muscle, and bone concentrations of ceforanide were significantly greater than those of cephalothin. These concentrations consistently exceeded the minimal inhibitory concentration for Staphylococcus aureus, the major pathogen implicated in wound infections. No toxicity was observed with either antibiotic. Ceforanide merits consideration as a prophylactic antibiotic in CABG operations.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
C. M. Conklin, R. J. Gray, D. Neilson, P. Wong, D. K. Tomita, and J. M. Matloff
Determinants of Wound Infection Incidence after Isolated Coronary Artery Bypass Surgery in Patients Randomized to Receive Prophylactic Cefuroxime or Cefazolin
Ann. Thorac. Surg., August 1, 1988; 46(2): 172 - 177.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
R. PLATT, A. MUNOZ, J. STELLA, S. VanDEVANTER, and J. K. KOSTER Jr.
Antibiotic Prophylaxis for Cardiovascular Surgery: Efficacy with Coronary Artery Bypass
Ann Intern Med, December 1, 1984; 101(6): 770 - 774.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The Society of Thoracic Surgeons.